Hypervision Surgical

100 Lambeth Palace Road, London Institute for Healthcare Engineering, London SE1 7AR, United Kingdom  All United Kingdom companies → — Founded 2020
Imaging AI Specialist Medical Device / Hardware Point-of-Care Diagnostics
General Surgery Neurosurgery Plastic Surgery
Surgical AI
Series A
Claim this company

Products

HyperSnap Surgical System (HSS)
Hypervision Surgical
Surgical AI
HyperSnap Surgical System by Hypervision Surgical is an AI-powered hyperspectral imaging platform that provides real-time, dye-free tissue oxygenation maps and conventional color video to enhance surgical precision and patient safety during open and minimally invasive procedures.

See all 1 product →

About Hypervision Surgical

Hypervision Surgical is a medical technology company that has developed an advanced surgical imaging and data analytics platform. Their core offering, the HYPERSNAP® Surgical System, utilizes hyperspectral imaging (HSI) combined with artificial intelligence (AI) to provide real-time, computer-assisted tissue analysis during surgical procedures. This innovative technology makes invisible tissue characteristics visible to surgeons without the need for contact or contrast agents. The system is capable of wide-field tissue differentiation, allowing for the identification of tumors, normal tissue, and critical structures such as nerves and blood vessels, as well as assessing tissue perfusion.

The company’s objective is to enhance surgical precision, speed, and patient safety by offering surgeons objective, data-driven information to facilitate better decision-making. Hypervision Surgical’s business model focuses on creating a hardware-agnostic software solution that can be integrated into existing surgical workflows, including minimally invasive, robotic, and microscopic surgeries. The HYPERSNAP® system has secured U.S. FDA 510(k) clearance and UKCA marking, and the company is currently conducting clinical evaluation studies in colorectal and neurosurgery, targeting the healthcare markets in Europe and the United States.

Focus Areas

AI-powered surgical imaging hyperspectral imaging real-time tissue analysis surgical precision patient safety intraoperative guidance medical devices computer vision machine learning

Business Intelligence

TechnologyHyperspectral Intelligence® platform, proprietary on-chip spectral sensing, patented AI analytics, cloud-scalable architecture, edge computing (NVIDIA IGX platform, NVIDIA Clara Holoscan SDK, NVIDIA Clara AGX developer kit)

What Physicians Need to Know

AI-Powered Hyperspectral Imaging
Hypervision Surgical utilizes AI-powered on-chip hyperspectral imaging (HSI) to provide real-time, data-driven insights into tissue properties during surgery. This technology goes beyond the limits of human vision by capturing spectral signatures invisible to the naked eye.
Real-time Tissue Analytics
The platform delivers real-time quantitative tissue oxygenation maps (StO2), perfusion assessment, and tissue differentiation, enabling surgeons to make more precise and informed decisions.
Enhanced Surgical Precision & Patient Safety
By providing objective, detailed tissue information, Hypervision Surgical aims to increase surgical precision, reduce complications like anastomotic leakage in colorectal surgery, and improve patient outcomes.
Seamless Integration
The ultra-compact, high-frame-rate spectral sensing systems are designed to integrate seamlessly into existing surgical vision platforms and workflows, overcoming previous barriers to HSI adoption in clinical practice.
Dye-Free Imaging
The technology is non-contact, non-invasive, and does not require exogenous contrast agents, preventing potential side effects and streamlining surgical procedures.
Regulatory Clearances
Hypervision Surgical's HYPERSNAP® platform is the world's first regulatory-cleared intraoperative imaging platform, with UKCA certification and FDA clearance for use in open and minimally invasive general surgery.
Specialized Applications
Key applications include colorectal surgery for real-time viability assessment at the anastomosis to reduce leak rates, and potential use in neurosurgery for tumor resection and other procedures.
Future Development
The company is advancing its technology to include high-resolution 3D stereoscopic vision systems for minimally invasive surgery, aiming to further enhance tissue characterization and surgical navigation.
Physician Tip

Hypervision Surgical's technology offers surgeons an objective, real-time 'superhuman vision' into tissue health, beyond what is visible to the naked eye. This can lead to more confident decision-making during critical surgical steps, potentially reducing complications and improving patient outcomes. The dye-free, non-invasive nature of the imaging simplifies workflow, and the seamless integration with existing surgical systems minimizes disruption. The ability to assess tissue oxygenation, perfusion, and differentiate tissue types in real-time can be particularly impactful in procedures like colorectal surgery to prevent anastomotic leaks, and in neurosurgery for precise tissue removal.

Hypervision Surgical's platform, HYPERSNAP®, is designed for seamless integration into existing surgical vision systems across open, minimally invasive, robotic, and microscopic platforms. The technology leverages on-chip HSI sensors developed in partnership with imec and is built on cloud computing platforms like NVIDIA's IGX platform, utilizing NVIDIA Clara Holoscan SDK for edge computing and AI-driven software development. This architecture allows for a scalable intelligence layer, transforming conventional surgical cameras into data-rich diagnostic tools.

Products by Hypervision Surgical

1 product in the directory

HyperSnap Surgical System (HSS)
Hypervision Surgical
Surgical AI
HyperSnap Surgical System by Hypervision Surgical is an AI-powered hyperspectral imaging platform that provides real-time, dye-free tissue oxygenation maps and conventional color video to enhance surgical precision and patient safety during open and minimally invasive procedures.

What the Web Says

As of early 2024, Hypervision Surgical is a relatively new company in the healthcare technology space, focusing on AI-powered surgical vision. Due to its nascent stage, there is limited public information and reviews available on major platforms like G2, Glassdoor, Capterra, or extensive healthcare IT review sites. Most available information comes from press releases, company announcements, and industry news outlets highlighting their technological advancements and funding rounds.

Overall: Positive

Strengths

  • Innovative technology in AI-powered surgical vision
  • Potential to improve surgical outcomes and efficiency
  • Strong focus on deep learning and hyperspectral imaging
  • Successful in securing significant seed funding
  • Collaboration with leading medical institutions (e.g., King's College London)

Limitations

  • Limited public product reviews due to early stage
  • No readily available employer reviews on Glassdoor or similar platforms
  • Technology is still in development/clinical trial phases, not widely deployed
  • Specific pricing and implementation details are not public
  • No direct user feedback on platforms like Reddit or G2 yet

Based on reviews from: Company press releases, Industry news articles (e.g., TechCrunch, Business Wire), King's College London announcements, Venture capital firm announcements (e.g., Northern Gritstone)

Last updated: 2026-10-16

Videos

News, demos, and interviews about Hypervision Surgical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Hypervision Surgical →

View all on YouTube

Press & Coverage

optics.org
Hypervision Surgical raises £17 million Series A funding to power surgical intelligence
Hypervision Surgical, a King's College London spin-out, secured £17 million in Series A funding to advance its hyperspectral bioimaging technology for real-time tissue viability assessment during surgery. The funding will accelerate commercial deployment of its Hyperspectral Intelligence platform and expand clinical adoption.
2026-05
healthcaretoday.com
Hypervision Surgical raises £17 million Series A
London-based Hypervision Surgical closed an oversubscribed £17 million Series A funding round to accelerate the commercial deployment of its real-time hyperspectral imaging platform, with investments from Heal Capital, Angelini Ventures, IP Group, Daycrest, ZEISS Ventures, Redalpine, Macmillan Cancer Support, and the SINC Fund.
2026-05
hypervisionsurgical.com
Hypervision Surgical receives FDA Clearance for HYPERSNAP® Surgical System to improve patient safety
Hypervision Surgical announced that the U.S. FDA granted 510(k) clearance for its HYPERSNAP® Surgical System, the first intraoperative platform combining Hyperspectral Imaging (HSI) with AI-powered analytics for real-time surgical decision support. The system also received a new FDA product code for AI/ML-based real-time video augmentation in imaging systems for surgery.
2025-07
hypervisionsurgical.com
Hypervision Surgical awarded the 2025 Lippmann Award and announces regulatory breakthroughs
Hypervision Surgical received the 2025 Lippmann Award for innovation in hyperspectral imaging and announced that in 2025, it became the first company globally to receive U.S. FDA clearance for real-time spectral imaging in surgery, including acceptance into the FDA Safer Technologies Program (STeP).
2025-11
hypervisionsurgical.com
Hypervision Surgical Achieves UKCA Marking for HYPERSNAP® Surgical System
Hypervision Surgical's HYPERSNAP® Surgical System received UK Conformity Assessed (UKCA) marking, signifying compliance with UK medical device standards and marking the first regulatory clearance of a real-time hyperspectral imaging-based medical device for enhanced surgical vision.
2024-12
imec-int.com
Hypervision Advances Surgical Intelligence with Next-Generation AI-Enabled Spectral Imaging
Following UKCA certification and FDA clearance, Hypervision Surgical is scaling its on-chip hyperspectral imaging (HSI) and real-time AI analytics to power global adoption of intelligent surgical vision. Imec and Hypervision have signed a strategic development agreement to co-develop scalable HSI technologies for surgical applications.
2025-07
nih.gov
Lightfield hyperspectral imaging in neuro-oncology surgery: an IDEAL 0 and 1 study
This study, funded by Hypervision Surgical Ltd, demonstrates the reliability and feasibility of a novel HSI system for real-time quantitative superficial tissue oxygenation information in bowel tissue alongside conventional RGB vision for surgical guidance. The system was used as the primary scope to complete a laparoscopic colorectal anastomosis in a live animal model.
2025-06
hypervisionsurgical.com
King's surgical AI spin-out Hypervision Surgical secures £6.5M seed investment
Hypervision Surgical, a King's College London spin-out, successfully completed an oversubscribed seed funding round, raising £6.5 million to accelerate the development of its vision technology and attain regulatory clearance in the United States and Europe.
2023-06

Frequently Asked Questions

Hypervision Surgical's core technology is the HYPERSNAP® Surgical System, which utilizes AI-powered hyperspectral imaging to provide real-time tissue analytics. This system extends a surgeon's vision beyond what the human eye can see by delivering quantitative information on tissue properties like oxygenation and perfusion, as well as differentiating between tissue types such as tumors, healthy tissue, nerves, and blood vessels. This objective, data-driven insight aims to improve surgical precision and patient safety by enabling more informed intraoperative decisions, potentially reducing complications like anastomotic leakage in colorectal surgery.
In colorectal surgery, Hypervision Surgical's technology focuses on mitigating anastomotic leakage by providing real-time tissue oxygenation maps, which are crucial for assessing tissue viability and selecting optimal resection margins. While the HYPERSNAP® system is cleared for general surgical applications, including minimally invasive procedures, the company's research also highlights its potential in oncology surgery for precise tissue differentiation, which is critical in procedures like brain tumor removal to balance maximal resection with healthy tissue preservation.
Hypervision Surgical's HYPERSNAP® Surgical System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and UK Conformity Assessed (UKCA) marking for general surgical applications, including both open and minimally invasive procedures. It is also the first device regulated under a new FDA product code for AI/ML-based real-time video augmentation in surgical imaging systems. Additionally, Hypervision Surgical has attained ISO 13485, ISO/IEC 27001:2022, and ISO/IEC 27701:2019 certifications, demonstrating their commitment to quality management, information security, and privacy.
The HYPERSNAP® Surgical System is designed for seamless integration into existing surgical workflows, compatible with exoscopes and rigid endoscopes for both open and minimally invasive surgeries. It operates at over 60 frames per second, providing continuous, real-time quantitative feedback without requiring exogenous contrast agents or disrupting the workflow. The system is built on the NVIDIA IGX platform, leveraging high-performance edge computing and AI inference for low-latency analytics.
Hypervision Surgical is a spin-out company from King's College London, founded by a team of clinicians, medical imaging, and AI experts. The company successfully closed an oversubscribed £17 million (approximately $23 million) Series A financing round in April 2026, led by Heal Capital with participation from other significant investors and strategic partners like SAGES Ingenuity and Macmillan Cancer Support. This funding is intended to accelerate commercial deployment, expand clinical adoption, and advance the development of their next-generation hyperspectral sensing technology.
Hypervision Surgical is actively engaged in multi-center clinical evaluations in UK hospitals and plans to expand its presence in the United States and selected European markets. They have a strategic development agreement with imec, a leading R&D hub for nanoelectronics, to co-develop scalable hyperspectral imaging technologies. The company also collaborates with NVIDIA, utilizing their Clara Holoscan SDK and Clara AGX developer kit for their AI-driven platform. For customer support, inquiries can be directed via email.

Investors

Who's funded Hypervision Surgical.

LifeX Ventures
VC T3
New York, United States
$1M-$5M
LifeX Ventures positions as a longevity and human-performance focused investor, backing companies at the intersection of biology, consumer health, and software. With…
AI/ML in Healthcare Biotech
Kings Health Partners Ventures
VC T3
London, United Kingdom
$250k-$1M
Kings Health Partners Ventures is the venturing arm of Kings Health Partners, the academic health science center comprising Kings College London and…
AI/ML in Healthcare Diagnostics

Related Companies

Surgical Reality
Nieuw-Vennep, The Netherlands

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]
Meril Life Sciences
Vapi, Gujarat, India

Meril Life Sciences is an Indian multinational medical device company dedicated to the innovation, design, and development of clinically relevant and state-of-the-art devices. The company focuses on alleviating human suffering and improving the quality of life through advanced healthcare solutions. Meril’s extensive product portfolio spans various medical fields, including vascular intervention, orthopedic implants, robotics, endosurgery, […]
Leap Rail
Houston, Texas

Leap Rail is a healthcare AI company that provides surgical healthcare management software designed to optimize operating room (OR) management and surgical scheduling. The platform leverages artificial intelligence, workflow automation, and patient, physician, and staff engagement to improve OR efficiency, block utilization, surgical staffing needs, and asset management. For physicians, Leap Rail offers tools that […]
Getinge
Gothenburg, Sweden

Getinge is a leading global medical technology company that provides innovative products and solutions to hospitals and life science institutions. The company’s offerings are designed to enhance clinical outcomes and optimize workflows across various healthcare settings. Getinge operates through three primary business areas: Acute Care Therapies, Surgical Workflows, and Life Sciences. For physicians, Getinge’s portfolio […]
IntelliLogic AI

IntelliLogic AI is a healthcare AI company that provides an AI-powered operating system specifically designed for medical device distributors and manufacturers. The platform aims to streamline and modernize medical device distribution, an industry that has traditionally relied on manual processes like spreadsheets and paper chargesheets. For physicians, IntelliLogic AI’s platform offers a comprehensive solution to […]
XACT Robotics
Caesarea, Israel, and Hingham, MA, USA

XACT Robotics is a privately held healthcare AI company focused on advancing the field of radiology with its hands-free robotic solutions for percutaneous procedures. The company’s flagship product, the XACT ACE® Robotic System, is designed to significantly improve targeting accuracy, efficiency, and consistency in these procedures. It integrates image-guided planning and real-time monitoring with precise […]
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.